Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.4.2' is shown and the older operating-status notice (v3.4.1) has been removed; these are maintenance updates and do not modify the study details.
    Difference
    0.5%
    Check dated 2026-02-11T11:43:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The update adds a government funding notice at the top and updates the page revision from v3.4.0 to v3.4.1, neither of which changes the study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:22:58.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata labels, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and introduced a new 'Revision: v3.4.0' entry.
    Difference
    0.2%
    Check dated 2026-01-28T06:22:45.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. The page content and study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-01-14T03:12:49.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Adds a Locations section listing participating sites in Illinois, Michigan, North Carolina, Ohio, Oregon, Pennsylvania, and South Carolina, and updates the page revision to v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-23T20:40:02.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now shows a new revision label v3.3.2, and the previous v3.2.0 label has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:42:12.000Z thumbnail image

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.